Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.
about
Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan.Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.Breed-predispositions to cancer in pedigree dogs.Histologic and immunohistochemical review of splenic fibrohistiocytic nodules in dogs.IL-12 based gene therapy in veterinary medicine.Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.Histiocytic sarcoma in 14 miniature schnauzers - a new breed predisposition?Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.Radiographic characterization of primary lung tumors in 74 dogs.A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy.Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.Amputation for histiocytic sarcoma in a cat.A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
P2860
Q33412761-A5DEF704-6D1C-4587-AB69-DDD1F91C1FB2Q35048722-DACB83BB-90F5-41E6-8324-76035488AAFEQ35931188-F6D9285E-718E-4A87-8C64-2A550336F1B1Q36857180-2345449F-A1EC-4DAE-89C5-B8E3E30F5567Q38033686-B6346DFE-D0D7-4549-A552-17CC788F8537Q38061510-64FF6112-43B8-4628-A810-E439F8FC4777Q38398467-13BA6662-C22C-4B85-8DC9-70362E3D2C69Q38764511-6B0E59BC-C55F-4974-A2A4-B3B51AEE7023Q38906083-3AFBE482-F17B-4B59-9B83-EE527DE99AC2Q45969252-BF403D28-E2F4-4B35-9CF8-F4CECADF18C2Q47108798-4302E2BF-E5CC-4369-B481-EA24CEA3D92EQ48263286-B7701DEA-F009-4D71-874A-768B9B6A6509Q48267879-58833257-D58D-4269-A7F3-DD39D61C90E4Q50931472-F4D12EDB-8345-4F2E-B015-36DA22C121FFQ51362148-2B04CC32-033E-4FE8-9A53-BDBDC874E3F0Q52681024-6860909E-372F-4D07-8F42-CD285D996810
P2860
Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@en
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@nl
type
label
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@en
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@nl
prefLabel
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@en
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@nl
P2093
P1476
Phase II, open-label trial of ...... untreated histiocytic sarcoma.
@en
P2093
D B Bailey
D S Russell
J L Intile
K M Rassnick
M A Kiselow
N C Northrup
P304
P356
10.1111/J.1939-1676.2010.0588.X
P577
2010-11-01T00:00:00Z